Results 1 to 10 of about 1,285 (207)

A comparison of the binding sites of antibodies and single-domain antibodies

open access: yesFrontiers in Immunology, 2023
Antibodies are the largest class of biotherapeutics. However, in recent years, single-domain antibodies have gained traction due to their smaller size and comparable binding affinity.
Gemma L. Gordon   +5 more
doaj   +5 more sources

Transportation of Single-Domain Antibodies through the Blood–Brain Barrier

open access: yesBiomolecules, 2021
Single-domain antibodies derive from the heavy-chain-only antibodies of Camelidae (camel, dromedary, llama, alpaca, vicuñas, and guananos; i.e., nanobodies) and cartilaginous fishes (i.e., VNARs).
Eduardo Ruiz-López   +1 more
doaj   +3 more sources

Single Domain Antibodies as New Biomarker Detectors [PDF]

open access: yesDiagnostics, 2017
Biomarkers are defined as indicators of biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention. Biomarkers have been widely used for early detection, prediction of response after treatment, and for ...
Chiuan Herng Leow   +5 more
doaj   +4 more sources

Brain Delivery of Single-Domain Antibodies: A Focus on VHH and VNAR

open access: yesPharmaceutics, 2020
Passive immunotherapy, i.e., treatment with therapeutic antibodies, has been increasingly used over the last decade in several diseases such as cancers or inflammation.
Elodie Pothin   +2 more
doaj   +3 more sources

An Inside Job: Applications of Intracellular Single Domain Antibodies [PDF]

open access: yesBiomolecules, 2020
Sera of camelid species contain a special kind of antibody that consists only of heavy chains. The variable antigen binding domain of these heavy chain antibodies can be expressed as a separate entity, called a single domain antibody that is ...
Eline Soetens   +2 more
doaj   +4 more sources

Immunogenicity and humanization of single‐domain antibodies [PDF]

open access: yesThe FEBS Journal, 2021
Single‐domain antibodies (sdAbs), the autonomous variable domains of camelid and shark heavy‐chain antibodies, have many desirable properties as components of biologic drugs. However, their sequences may increase the risk of immunogenicity and antidrug antibody (ADA) development in humans, and thus, sdAbs are routinely humanized during development ...
Rossotti, Martin A.   +3 more
openaire   +2 more sources

Single-domain antibodies make a difference [PDF]

open access: yesScience, 2021
A double hit with one antibody construct may avoid viral ...
Xavier, Saelens, Bert, Schepens
openaire   +2 more sources

Importance of Hypervariable Region 2 for Stability and Affinity of a Shark Single-Domain Antibody Specific for Ebola Virus Nucleoprotein. [PDF]

open access: yesPLoS ONE, 2016
Single-domain antibodies derived from the unique New Antigen Receptor found in sharks have numerous potential applications, ranging from diagnostic reagents to therapeutics.
George P Anderson   +7 more
doaj   +1 more source

Integrating Single Domain Antibodies into Field-Deployable Rapid Assays

open access: yesAntibodies, 2022
Single domain antibodies (sdAb) are the recombinant variable heavy domains derived from camelid heavy-chain antibodies. While they have binding affinities equivalent to conventional antibodies, sdAb are only one-tenth the size and possess numerous ...
George P. Anderson   +3 more
doaj   +1 more source

Development and evaluation of single domain antibodies for vaccinia and the L1 antigen. [PDF]

open access: yesPLoS ONE, 2014
There is ongoing interest to develop high affinity, thermal stable recognition elements to replace conventional antibodies in biothreat detection assays. As part of this effort, single domain antibodies that target vaccinia virus were developed.
Scott A Walper   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy